Advertisement

PAIN MEDICATION USE IN OLDER IRISH ADULTS WITH OSTEOARTHRITIS FROM THE IRISH LONGITUDINAL STUDY ON AGEING (TILDA): A CROSS-SECTIONAL STUDY

      Purpose: Osteoarthritis (OA) is the most common form of arthritis and a leading cause of pain and disability worldwide. Due to the older age profile of people with OA and the presence of comorbidities such as cardiovascular disease, hypertension, diabetes and lung disease, the safety of pharmacological approaches, as well as their efficacy, need to be considered in ascertaining their role in managing OA. Pharmacological management of OA centres on management of symptoms and includes analgesics, non-steroidal anti-inflammatory drugs (NSAIDs), opioids and nutraceuticals (e.g. glucosamine/chondroitin sulphate). Little is known about how OA is managed in Ireland. This research aimed to explore the utilisation of medications and nutraceuticals typically used to manage the symptoms of OA among individuals with self-reported OA from The Irish Longitudinal Study on Ageing (TILDA) population cohort study. The aim of this study was to compare cross-sectional patterns of pain medications and nutraceutical use in individuals with OA compared to those without any type of arthritis in an Irish population cohort, and to examine the relationship between the total number of these medications used and demographic and clinical factors.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Osteoarthritis and Cartilage
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect